Global Phase 2b Trial Launching of Tesomet in Easing Hyperphagia

Global Phase 2b Trial Launching of Tesomet in Easing Hyperphagia

315184

Global Phase 2b Trial Launching of Tesomet in Easing Hyperphagia

Saniona is launching a Phase 2b clinical trial of Tesomet to evaluate its potential in lessening the uncontrollable hunger of people with Prader-Willi syndrome (PWS). “The initiation of this Phase 2b clinical trial of Tesomet in Prader-Willi syndrome follows our recent initiation of a Phase 2b clinical trial of Tesomet in hypothalamic obesity — two serious diseases with high unmet need,” Rudolf Baumgartner, MD, Saniona’s chief medical officer and head of clinical development, said in a press…

You must be logged in to read/download the full post.